16 Einträge gefunden

1. Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation

   1. Wagner-Drouet, Eva
   2. Teschner, Daniel
   3. Wolschke, Christine
   4. Schäfer-Eckart, Kerstin
   5. Gärtner, Johannes
   6. Mielke, Stephan
   7. Schreder, Martin

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)

   1. Kröger, Nicolaus
   2. Sockel, Katja
   3. Wolschke, Christine
   4. Bethge, Wolfgang
   5. Schlenk, Richard F
   6. Wolf, Dominik
   7. Stadler, Michael

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor

   1. Morris, Curly
   2. Chabannon, Christian
   3. Masszi, Tamas
   4. Russell, Nigel
   5. Nahi, Hareth
   6. Kobbe, Guido
   7. Krejci, Marta

   2020 - Forschungsinformationssystem des UKE
4. Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1

   1. Eberhard, Johanna M
   2. Angin, Mathieu
   3. Passaes, Caroline
   4. Salgado, Maria
   5. Monceaux, Valerie
   6. Knops, Elena
   7. Kobbe, Guido

   2020 - Forschungsinformationssystem des UKE
5. Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents

   1. Sahebi, Firoozeh
   2. Iacobelli, Simona
   3. Sbianchi, Giulia
   4. Koster, Linda
   5. Blaise, Didier
   6. Reményi, Péter
   7. Russell, Nigel H

   2018 - Forschungsinformationssystem des UKE
6. Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

   1. Auner, Holger W
   2. Iacobelli, Simona
   3. Sbianchi, Giulia
   4. Knol-Bout, Cora
   5. Blaise, Didier
   6. Russell, Nigel H
   7. Apperley, Jane F

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
7. Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

   1. Ayuk, Francis
   2. Beelen, Dietrich W
   3. Bornhäuser, Martin
   4. Stelljes, Matthias
   5. Zabelina, Tatyana
   6. Finke, Jürgen
   7. Kobbe, Guido

   2018 - Forschungsinformationssystem des UKE
8. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
9. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

   1. Alchalby, Haefaa
   2. Yunus, Dinah-Rohina
   3. Zabelina, Tatjana
   4. Kobbe, Guido
   5. Holler, Ernst
   6. Bornhäuser, Martin
   7. Schwerdtfeger, Rainer

   2012 - Forschungsinformationssystem des UKE
10. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.

    1. Klyuchnikov, Evgeny
    2. Holler, Ernst
    3. Bornhäuser, Martin
    4. Kobbe, Guido
    5. Nagler, Arnon
    6. Shimoni, Avichai
    7. Könecke, Christian

    2012 - Forschungsinformationssystem des UKE
11. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.

    1. Gökbuget, Nicola
    2. Basara, Nadezda
    3. Baurmann, Herrad
    4. Beck, Joachim
    5. Brüggemann, Monika
    6. Diedrich, Helmut
    7. Güldenzoph, Björn

    2011 - Forschungsinformationssystem des UKE
12. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

    1. Wolff, Daniel
    2. Schleuning, Michael
    3. von Harsdorf, Stephanie
    4. Bacher, Ulrike
    5. Gerbitz, Armin
    6. Stadler, Michael
    7. Ayuketang Ayuk, Francis

    2011 - Forschungsinformationssystem des UKE
13. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.

    1. Alchalby, Haefaa
    2. Badbaran, Anita
    3. Zabelina, Tatjana
    4. Kobbe, Guido
    5. Hahn, Joachim
    6. Wolff, Daniel
    7. Bornhäuser, Martin

    2010 - Forschungsinformationssystem des UKE
14. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

    1. Kröger, Nicolaus
    2. Holler, Ernst
    3. Kobbe, Guido
    4. Bornhäuser, Martin
    5. Schwerdtfeger, Rainer
    6. Baurmann, Herrad
    7. Nagler, Arnon

    2009 - Forschungsinformationssystem des UKE
15. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).

    1. Platzbecker, Uwe
    2. Bornhäuser, Martin
    3. Germing, Ulrich
    4. Stumpf, Julian
    5. Scott, Bart L
    6. Kröger, Nicolaus
    7. Schwerdtfeger, Rainer

    2008 - Forschungsinformationssystem des UKE
16. Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

    1. Kröger, Nicolaus
    2. Badbaran, Anita
    3. Holler, Ernst
    4. Hahn, Joachim
    5. Kobbe, Guido
    6. Bornhäuser, Martin
    7. Reiter, Andreas

    2007 - Forschungsinformationssystem des UKE